An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer and ...
Cathy Eng, professor and director, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, says mutation testing is done to determine which, if any, therapies ...
- More than 15,000 new cases of follicular lymphoma are diagnosed each year in the US, and about 20 percent of patients will relapse within two years, with few treatment options[1] - The new cobas ...
(RTTNews) - Swiss drug maker Roche Group (RHHBY) announced Tuesday the launch of the cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer. The cobas PIK3CA Mutation Test ...
After a breast-cancer diagnosis and a separate scare, my mom tested for the BRCA2 gene mutation. Knowing it could be hereditary, I decided to get tested at 23 to see if I also carried the mutation. My ...
Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
NEW YORK, Sept 14 (Reuters) - Pfizer (PFE.N), opens new tab is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug Braftovi, which the ...
NEW YORK, NY, USA, January 2, 2024 /EINPresswire.com/ -- Creative Bioarray, a leading provider of high-quality research solutions in the field of biotechnology ...
Gila Pfeffer is a humor writer who splits her time between NYC and London. The following is an adapted excerpt from her memoir, "Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results